Société Cerevel Therapeutics Holdings, Inc.
Actions
CERE
US15678U1280
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
42,1 USD | -0,59 % | -0,21 % | -0,71 % |
Métier
Nombre d'employés: 355
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12/06/23 |
Director of Finance/CFO | 42 | 15/05/23 | |
N. Coles
CHM | Chairman | 63 | 01/12/18 |
Raymond Sanchez
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/19 |
John Renger
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/05/19 |
53 | - | ||
Matthew Calistri
IRC | Investor Relations Contact | - | - |
Scott Akamine
LAW | General Counsel | 40 | 24/05/21 |
Mark Bodenrader
AUD | Comptroller/Controller/Auditor | 51 | 01/09/19 |
Paul Burgess
PRN | Corporate Officer/Principal | 50 | 20/06/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 63 | 01/06/19 | |
Douglas Giordano
BRD | Director/Board Member | 61 | 01/09/18 |
Ruth McKernan
BRD | Director/Board Member | 66 | 04/12/20 |
Deval Patrick
BRD | Director/Board Member | 67 | 20/01/21 |
Marijn Dekkers
BRD | Director/Board Member | 65 | 01/09/18 |
Norbert Riedel
BRD | Director/Board Member | 66 | 01/12/18 |
N. Coles
CHM | Chairman | 63 | 01/12/18 |
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12/06/23 |
Director/Board Member | 51 | 01/09/18 | |
Deborah Baron
BRD | Director/Board Member | 55 | 20/01/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 182 194 722 | 77 490 691 ( 42,53 %) | 0 | 42,53 % |
Coordonnées société
Cerevel Therapeutics Holdings, Inc.
222 Jacobs Street Suite 200
02141, Cambridge
+844 304 2048
http://www.cerevel.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-0,71 % | 7,67 Md | |
+9,42 % | 115 Md | |
+11,84 % | 106 Md | |
-1,05 % | 21,96 Md | |
-14,15 % | 21,87 Md | |
-5,29 % | 19,21 Md | |
-4,16 % | 18,08 Md | |
-38,29 % | 17,71 Md | |
+7,99 % | 14,32 Md | |
+36,24 % | 12,42 Md |
- Bourse
- Actions
- Action CERE
- Société Cerevel Therapeutics Holdings, Inc.